TIMOTHY M MAYLEBEN
CIK 1242613 · Interim CEO · last filed 2025-02-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$386.5K
Companies
7
Total Filings
75
Lifetime Open-Market Net
-$370.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Director | 2,300 | $0.55 | $1.3K | $0 | 17 | 2025-02-11 |
| Landos Biopharma, Inc. (LABP) Delisted | Interim CEO | — | $22.93 | — | $0 | 5 | 2024-05-23 |
| ESPR | President & CEO | 122,698 | $3.15 | $386.5K | $2.22M | 26 | 2021-01-29 |
| Loxo Oncology, Inc. (LOXO) Delisted | Director | 7,416 | — | — | -$2.83M | 8 | 2019-02-15 |
| Vericel Corp (ASTM) Delisted | President and CEO | 133,000 | — | — | $189.9K | 11 | 2012-08-30 |
| Vericel Corp (ASTMD) Delisted | CEO, President, CFO & Director | 18,068 | — | — | $49.6K | 2 | 2010-03-15 |
| NightHawk Radiology Holdings Inc (NHWK) Delisted | Chief Operating Officer | — | $0.41 | — | $0 | 2 | 2008-02-21 |
Recent Filings · Page 4 of 8
75 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-02-01 | ESPR | Exer (M) | +4,549 | $5.3K | EDGAR |
| 2018-01-29 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | +4,500 | $0 | EDGAR |
| 2018-01-29 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | +3,300 | $0 | EDGAR |
| 2018-01-03 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2017-12-22 | Loxo Oncology, Inc. (LOXO) Delisted | Sell (S) | −10,000 | -$804.9K | EDGAR |
| 2017-12-08 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-27 | Loxo Oncology, Inc. (LOXO) Delisted | Mixed | — | -$164.8K | EDGAR |
| 2017-06-23 | Loxo Oncology, Inc. (LOXO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-22 | ESPR | Grant (A) | — | $0 | EDGAR |
| 2017-01-19 | MARINUS PHARMACEUTICALS, INC. (MRNS) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.